SCHEMBL4757495

SCHEMBL4757495

CC(=O)Oc1cc(C)c(Cl)cc1C(=O)Nc1nc(NS(C)(=O)=O)c(F)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
RXFP1 Q9HBX9 2/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 6/20 0.36
NPC1 O15118 5/20 0.36
AGER Q15109 1/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
TP53 P04637 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 2/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
GLA P06280 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
DCLK1 O15075 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756645 0.77 NPC1 (0.41) KDM4ENPSR1RXFP1GAARAB9A
SCHEMBL4757428 0.74 NPC1 (0.42) KDM4ENPSR1RXFP1GAARAB9A
SCHEMBL4756830 0.73 ABL1 (0.38) KDM4EGAARAB9ANPC1AGER
SCHEMBL4757501 0.69 POLB (0.37) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL4757479 0.66 KCNMA1 (0.46) KDM4ENPSR1RXFP1GAARAB9A
SCHEMBL10114545 0.66 SCN9A (0.41) NPSR1RAB9ANPC1KMT2AMEN1
SCHEMBL10114630 0.66 SCN9A (0.41) SCN9A
SCHEMBL167764 0.65 POLB (0.51) KDM4ENPSR1GAARAB9ANPC1
SCHEMBL4757405 0.65 MEN1 (0.46) KDM4ERXFP1RAB9ANPC1KMT2A
SCHEMBL10114719 0.65 KDM4E (0.39) KDM4ERXFP1GAARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDM4E 2428/4885NPSR1 4396/4885RXFP1 4741/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDM4E 2428/4885NPSR1 4396/4885RXFP1 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.